Curated News:

National Institutes of Health (NIH)

Add to Favorites Subscribe Share

Collaboration reveals potential new therapy for osteoarthritis

Cornell University

Osteoarthritis affects 240 million people worldwide and is one of the most common causes of disability in both humans and animals. Currently, no therapeutics exist to prevent this disease, but recent multidisciplinary research at Cornell reveals that the application of a proprietary peptide known as SS-31 may protect cartilage from the injury that leads to arthritis.

Channels: All Journal News, Pharmaceuticals, National Institutes of Health (NIH),

Released:
22-Jan-2020 12:15 PM EST
Embargo will expire:
27-Jan-2020 5:00 AM EST
Released to reporters:
22-Jan-2020 11:35 AM EST

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Jan-2020 5:00 AM EST

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Research Results

Study takes on e-cigarette warning ‘paradox’

Cornell University

As controversy swirls around the vaping industry, a team of Cornell researchers has set out to help regulators identify the most effective health warnings to include in advertisements for electronic cigarettes.

Channels: Children's Health, Government/Law, Public Health, Smoking, Technology, National Cancer Institute (NCI), National Institutes of Health (NIH), All Journal News,

Released:
21-Jan-2020 3:05 PM EST
Research Results

Clinical Trial: Vitamin D Supplementation Linked to Potential Improvements in Blood Pressure in Children

Health Sciences at the University of Pittsburgh

Overweight and obese vitamin D-deficient children who took a relatively high dose of vitamin D every day for six months had lower blood pressure and improved insulin sensitivity than their peers who took a lower dose, according to the results of a new clinical trial.

Channels: Cardiovascular Health, Children's Health, Clinical Trials, Diabetes, Obesity, Pharmaceuticals, National Institutes of Health (NIH), All Journal News, Grant Funded News,

Released:
21-Jan-2020 11:05 AM EST
Research Results
Newswise: Dozens of potential anti-cancer drugs netted in massive screening study
  • Embargo expired:
    20-Jan-2020 11:00 AM EST

Dozens of potential anti-cancer drugs netted in massive screening study

Dana-Farber Cancer Institute

A variety of existing drugs for treating conditions such as diabetes, inflammation, alcohol abuse, and arthritis in dogs can also kill cancer cells in the lab, according to a study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard.

Channels: All Journal News, Grant Funded News, Cancer, Clinical Trials, Pharmaceuticals, National Institutes of Health (NIH), Nature (journal),

Released:
19-Jan-2020 11:05 AM EST
Research Results

New Drug Prevents Liver Damage, Obesity and Glucose Intolerance in Mice on High-Fat Diet

Georgetown Lombardi Comprehensive Cancer Center

Mice given a new drug targeting a key gene involved in lipid and glucose metabolism could tolerate a high-fat diet regimen (composed of 60% fat from lard) without developing significant liver damage, becoming obese, or disrupting their body’s glucose balance.

Channels: Clinical Trials, Liver Disease, Obesity, Pharmaceuticals, Weight Loss, National Institutes of Health (NIH), Grant Funded News,

Released:
20-Jan-2020 10:50 AM EST
Research Results
Newswise: Human fetal lungs harbor a microbiome signature

Human fetal lungs harbor a microbiome signature

University of Alabama at Birmingham

The lungs and placentas of fetuses in the womb — as young as 11 weeks after conception — already show a bacterial microbiome signature, which suggests that bacteria may colonize the lungs well before birth. How the microbes or microbial products reach those organs before birth is not known.

Channels: All Journal News, Immunology, Microbiome, OBGYN, National Institutes of Health (NIH), Staff Picks,

Released:
17-Jan-2020 12:50 PM EST
Research Results
Newswise: 221604_web.jpg
Released:
17-Jan-2020 1:40 AM EST
Research Results
uci-full-wordmark-blue.png

Putting the ‘lazy eye' to work

University of California, Irvine

When University of California, Irvine neurobiologist Carey Y.L. Huh, Ph.D., set her sights on discovering more about amblyopia, she brought personal insight to her quest. As a child, Huh was diagnosed with the condition, which is often called “lazy eye.” he and her colleagues have just found that amblyopia originates in an earlier stage of the visual pathway than was previously thought. Their research, which raises the possibility of new treatment approaches, appears in the Journal of Neuroscience.

Channels: Pharmaceuticals, Vision, National Institutes of Health (NIH), Children's Health, Healthcare, All Journal News, Staff Picks,

Released:
17-Jan-2020 12:20 AM EST
Research Results


1.70623